Drug Trial Radar · NCT07598890
Phase I Clinical Trial of Adsorbed Tetanus Vaccine
Last checked: Nov 20, 2026Latest source record: Sep 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
80
Planned (sponsor's estimate)
Start
May 21, 2026
Primary completion
Jun 20, 2026
Study completion Dec 31, 2026
Sponsor
- Lead sponsor
- Aimei Vacin BioPharm (Zhejiang) Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- May 20, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is a randomized, double-blind, parallel-controlled Phase I clinical trial of Adsorbed Tetanus Vaccine. Participants aged ≥18 years will receive one dose of the vaccine to evaluate its safety and immunogenicity.
Conditions
- Tetanus
Interventions
Tetanus Vaccine, AdsorbedBiological
This investigational vaccine is manufactured by AIM Persistence Biopharmaceutical Co., Ltd. Participants will receive one dose of adsorbed tetanus vaccine via intramuscular injection into the deltoid muscle of the upper arm.
Tetanus Vaccine, AdsorbedBiological
This control vaccine is manufactured by Chengdu Olymvax Biopharmaceuticals Inc. Participants will receive one dose of adsorbed tetanus vaccine via intramuscular injection into the deltoid muscle of the upper arm.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of adverse events (AEs) and adverse reactions (ARs).Time frame: Within 7 days after vaccination
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Hubei Provincial Center for Disease Control and Prevention
Wuhan, Hubei, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.